Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02QZR
|
|||
| Former ID |
DIB007808
|
|||
| Drug Name |
LY-545694
|
|||
| Synonyms |
Lead iGluR5 antagonist (pain), Eli Lilly
Click to Show/Hide
|
|||
| Indication | Neuropathic pain [ICD-11: 8E43.0] | Phase 2 | [1] | |
| Company |
Eli Lilly & Co
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutamate receptor ionotropic (GRI) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00785577) A Study for Treatment of Pain in Patients With Diabetic Neuropathy.. U.S. National Institutes of Health. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019739) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.